International registry of robot-assisted minimally invasive surgery for gastric cancer
The UGIRA International Registry for Robot-Assisted Minimally Invasive Gastrectomy (RAMIG) for Gastric Cancer
This registry will collect information to see how robot-assisted minimally invasive gastrectomy (RAMIG) works and how surgeons learn it for people having surgery for gastric cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT07517432 on ClinicalTrials.gov |
What this trial studies
This observational international registry, led from The Chinese University of Hong Kong, collects standardized perioperative and postoperative data on patients undergoing robot-assisted minimally invasive gastrectomy (RAMIG). It aims to harmonize definitions of outcomes so results can be compared across centers, capture variations in surgical technique, and quantify the learning curve for surgeons adopting RAMIG. Data elements include patient characteristics, surgical details, complications, oncologic metrics, and hospital stay. Aggregated results will be used to inform safer and more effective implementation of RAMIG worldwide.
Who should consider this trial
Good fit: Patients with gastric cancer who undergo robot-assisted minimally invasive gastrectomy at a participating center are ideal candidates for inclusion.
Not a fit: Patients who are not treated with RAMIG (for example those undergoing open surgery, non-surgical management, or surgery at non-participating centers) would not directly benefit from this registry.
Why it matters
Potential benefit: If successful, the registry could help surgeons adopt RAMIG more safely and consistently, potentially reducing complications and improving recovery for patients.
How similar studies have performed: Numerous single-center and comparative studies have shown robotic gastrectomy to be feasible and safe, but large international registries standardizing outcomes and learning-curve data remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All gastric cancer patients undergoing RAMIG in a center Exclusion Criteria: * No
Where this trial is running
Hong Kong
- The Chinese University of Hong Kong, Shatin, HK — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Shannon Melissa CHAN, MBChB, FRCSEd, FHKAM (Surgery) — Chinese University of Hong Kong
- Study coordinator: Shannon Melissa CHAN, MBChB, FRCSEd, FHKAM (Surgery)
- Email: shannonchan@surgery.cuhk.edu.hk
- Phone: +852 3505 2956
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.